IL6 and Insulin resistance: Among the immune pathways, IL-6 was found to be the major cytokine involved in NOD after AP, causing an impaired phosphorylation of the insulin receptor and insulin receptor substrate-1 and leading to insulin resistance (a 1 ng/mL increase in IL-6 was associated with a 0.7% increase in insulin resistance) [27].